trastuzumab
Not Tagged
['trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)']
do tils predict benefit from trastuzumab therapy in her2+ bc?
meta-analysis by #ebctcg of individual patient data from 5 trials (4,000pts) at #asco23 - tils are prognostic: tils= recurrence risk - tils were not predictive: effect of trastuzumab consistent regardless of tils 
MD, Medical Oncologist🇮🇹•Research Fellow at @JulesBordet Institute in Brussels🇧🇪 Great interest in #BreastCancer and #ImmunoOncology